Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omalizumab in inner-city children with asthma
NCT00377572Phase 4Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Oct 2006
- Primary completion
- Dec 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Omalizumab + Conventional Therapy with Placebo + Conventional Therapy (2 arms). Primary endpoint: Maximum Number of Asthma Symptom Days. Started Oct 2006; status: completed.
02
Drugs
omalizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00377572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00377572.